Lifecore Biomedical (LFCR) News Today $5.72 -0.51 (-8.19%) Closing price 04/10/2025 04:00 PM EasternExtended Trading$5.63 -0.09 (-1.56%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Lifecore Biomedical, Inc. (NASDAQ:LFCR) Stock Position Decreased by Wittenberg Investment Management Inc.Wittenberg Investment Management Inc. lowered its holdings in Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) by 80.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 11,223 shares of the company's stock aftApril 6, 2025 | marketbeat.comLifecore Biomedical (NASDAQ:LFCR) Announces Earnings Results, Misses Estimates By $0.05 EPSLifecore Biomedical (NASDAQ:LFCR - Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.19) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.05). Lifecore Biomedical had a negative net margin of 12.52% and a negative return on equity of 315.23%.April 5, 2025 | marketbeat.comLifecore Biomedical (LFCR) Gets a Hold from BarringtonApril 5, 2025 | markets.businessinsider.comLifecore Biomedical, Inc. (NASDAQ:LFCR) Q3 2025 Earnings Call TranscriptApril 5, 2025 | insidermonkey.com43,700 Shares in Lifecore Biomedical, Inc. (NASDAQ:LFCR) Purchased by Rangeley Capital LLCRangeley Capital LLC acquired a new stake in Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 43,700 shares of the company's stock,April 5, 2025 | marketbeat.comLifecore Biomedical Reports Q3 Fiscal 2025 ResultsApril 4, 2025 | tipranks.comLifecore Biomedical targets 12% revenue CAGR and expanded CDMO pipeline by 2027April 3, 2025 | msn.comLifecore Biomedical, Inc. (LFCR) Q3 2025 Earnings Call TranscriptApril 3, 2025 | seekingalpha.comLifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate UpdateApril 3, 2025 | globenewswire.comLifecore Biomedical (LFCR) Expected to Announce Earnings on ThursdayApril 2, 2025 | americanbankingnews.comCraig-Hallum Keeps Their Buy Rating on Lifecore Biomedical (LFCR)April 1, 2025 | markets.businessinsider.comLifecore Biomedical (LFCR) to Release Earnings on ThursdayLifecore Biomedical (NASDAQ:LFCR) will be releasing earnings on Thursday, April 3, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=633032)March 29, 2025 | marketbeat.comLifecore Biomedical to Report Financial Results for Third Quarter of Fiscal 2025 on April 3, 2025March 27, 2025 | globenewswire.comDCF Advisers LLC Acquires 251,511 Shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR)DCF Advisers LLC lifted its holdings in Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) by 87.2% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 539,989 shares of the company's stock after purchasing an additional 251,5March 22, 2025 | marketbeat.comHumanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation SyndromeMarch 17, 2025 | finance.yahoo.comHumanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation SyndromeMarch 17, 2025 | globenewswire.comLifecore Biomedical (NASDAQ:LFCR) Trading 0.5% Higher - Should You Buy?Lifecore Biomedical (NASDAQ:LFCR) Trading Up 0.5% - Here's WhyMarch 9, 2025 | marketbeat.comIs Lifecore Biomedical, Inc. (LFCR) the Best Micro Cap Stock to Buy Now?March 7, 2025 | insidermonkey.comGreenhaven Road Capital’s Updates on Lifecore Biomedical (LFCR)March 7, 2025 | msn.comLifecore Biomedical: We Are Not Playing To Make 5% Or 10% HereMarch 3, 2025 | seekingalpha.comLifecore Biomedical to Participate in Upcoming Investor and Industry ConferencesFebruary 26, 2025 | globenewswire.comLifecore Biomedical (NASDAQ:LFCR) Stock Price Up 3.8% - Should You Buy?Lifecore Biomedical (NASDAQ:LFCR) Stock Price Up 3.8% - Still a Buy?February 14, 2025 | marketbeat.comLifecore Biomedical to Participate in 2025 BIO CEO & Investor ConferenceFebruary 3, 2025 | globenewswire.comLifecore Biomedical’s Earnings Call: Growth Amid ChallengesJanuary 28, 2025 | tipranks.comThis Lifecore Biomedical Insider Increased Their Holding In The Last YearJanuary 26, 2025 | finance.yahoo.comHere are Laughing Water Capital’s Updates on Lifecore Biomedical (LFCR)January 22, 2025 | msn.comShort Interest in Lifecore Biomedical, Inc. (NASDAQ:LFCR) Increases By 6.4%Lifecore Biomedical, Inc. (NASDAQ:LFCR - Get Free Report) saw a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 2,500,000 shares, an increase of 6.4% from the December 15th total of 2,350,000 shares. Based on an average daily trading volume, of 240,000 shares, the short-interest ratio is presently 10.4 days. Currently, 7.6% of the shares of the company are sold short.January 19, 2025 | marketbeat.comLifecore Biomedical Announces Special Stockholder MeetingJanuary 17, 2025 | globenewswire.comResearch Analysts Offer Predictions for LFCR FY2025 EarningsLifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) - Research analysts at Barrington Research increased their FY2025 earnings per share (EPS) estimates for Lifecore Biomedical in a note issued to investors on Wednesday, January 8th. Barrington Research analyst M. Petusky now anticipates that tJanuary 10, 2025 | marketbeat.comLifecore Biomedical’s Strategic Asset Sale Supports Hold Rating Amid Leverage ConcernsJanuary 9, 2025 | markets.businessinsider.comLifecore Biomedical, Inc.: Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 MillionJanuary 8, 2025 | finanznachrichten.deLifecore Biomedical, Inc. (NASDAQ:LFCR) CEO Paul Josephs Acquires 17,000 SharesLifecore Biomedical, Inc. (NASDAQ:LFCR - Get Free Report) CEO Paul Josephs acquired 17,000 shares of the business's stock in a transaction that occurred on Wednesday, January 8th. The shares were acquired at an average cost of $5.74 per share, with a total value of $97,580.00. Following the completion of the transaction, the chief executive officer now directly owns 559,717 shares in the company, valued at approximately $3,212,775.58. The trade was a 3.13 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.January 8, 2025 | marketbeat.comLifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 MillionJanuary 7, 2025 | globenewswire.comLifecore Biomedical to Participate at 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 6, 2025 | globenewswire.comLifecore Biomedical, Inc. (NASDAQ:LFCR) Q2 2025 Earnings Call TranscriptJanuary 4, 2025 | insidermonkey.comStocks to Watch: Lifecore Biomedical, Resources ConnectionJanuary 4, 2025 | marketwatch.comBarrington Keeps Their Hold Rating on Lifecore Biomedical (LFCR)January 4, 2025 | markets.businessinsider.comLifecore Biomedical's (LFCR) "Equal Weight" Rating Reaffirmed at StephensStephens reiterated an "equal weight" rating and set a $6.00 price objective on shares of Lifecore Biomedical in a report on Friday.January 3, 2025 | marketbeat.comLifecore Biomedical, Inc.: Lifecore Biomedical Reports Second Quarter Fiscal 2025 Financial Results and Provides Corporate UpdateJanuary 3, 2025 | finanznachrichten.deLifecore Biomedical reports Q2 EPS (25c), two estimates (31c)January 3, 2025 | markets.businessinsider.comLifecore Biomedical (NASDAQ:LFCR) Stock Quotes, Forecast and News SummaryJanuary 3, 2025 | benzinga.comLifecore Biomedical (LFCR) Reports Q2 Loss, Tops Revenue EstimatesJanuary 3, 2025 | msn.comLifecore Biomedical Reports Q2 Fiscal 2025 ResultsJanuary 2, 2025 | tipranks.comLifecore Biomedical, Inc. (LFCR) Q2 2025 Earnings Call TranscriptJanuary 2, 2025 | seekingalpha.comLifecore Biomedical Swings to 2Q Loss Despite Higher SalesJanuary 2, 2025 | marketwatch.comLifecore Biomedical (NASDAQ:LFCR) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPSLifecore Biomedical (NASDAQ:LFCR - Get Free Report) posted its earnings results on Thursday. The company reported ($0.25) earnings per share for the quarter, topping analysts' consensus estimates of ($0.27) by $0.02. Lifecore Biomedical had a negative return on equity of 382.65% and a net margin of 5.09%.January 2, 2025 | marketbeat.comLifecore Biomedical Reports Second Quarter Fiscal 2025 Financial Results and Provides Corporate UpdateJanuary 2, 2025 | globenewswire.comIs Now The Time To Look At Buying Lifecore Biomedical, Inc. (NASDAQ:LFCR)?December 30, 2024 | uk.finance.yahoo.comLifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025December 19, 2024 | globenewswire.comLifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder TreatmentDecember 19, 2024 | globenewswire.com Remove Ads Get Lifecore Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for LFCR and its competitors with MarketBeat's FREE daily newsletter. Email Address LFCR Media Mentions By Week LFCR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LFCR News Sentiment▼0.170.93▲Average Medical News Sentiment LFCR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LFCR Articles This Week▼74▲LFCR Articles Average Week Remove Ads Get Lifecore Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for LFCR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Mineralys Therapeutics News Today Spyre Therapeutics News Today Enliven Therapeutics News Today Collegium Pharmaceutical News Today Nurix Therapeutics News Today Vir Biotechnology News Today Phibro Animal Health News Today Xeris Biopharma News Today Oculis News Today Zymeworks News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LFCR) was last updated on 4/11/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lifecore Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lifecore Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
